The DOI matches its Crossref record; 319 of the 319 references it cites were found in a registry or an index.
A comprehensive review of amyotrophic lateral sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a late-onset fatal neurodegenerative disease affecting motor neurons with an incidence of about 1/100,000. Most ALS cases are sporadic, but 5-10% of the cases are familial ALS. Both sporadic and familial ALS (FALS) are associated with degeneration of cortical and spinal motor neurons. The etiology of ALS remains unknown. However, mutations of superoxide dismutase 1 have been known as the most common cause of FALS. In this study, we provide a comprehensive review of ALS. We cover all aspects of the disease including epidemiology, comorbidities, environmental risk factor, molecular mechanism, genetic factors, symptoms, diagnostic, treatment, and even the available supplement and management of ALS. This will provide the reader with an advantage of receiving a broad range of information about the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · cited 6×
“Criteria and requirements for diagnosis The El Escorial criteria for diagnosing ALS was published in 1994 by the World Federation of Neurology for inclusion standards for patients entering research studies and clinical trials.[3,35] The importance of laboratory exams as diagnostic tools to exclude differential diagnos…”
BackgroundMethodInfluentialKiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,553
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
The induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605
Free radicals and antioxidants in human health: current status and future prospects.
Devasagayam, T. P. A., Tilak, J. C., Boloor, K. K., Sane, K. S., Ghaskadbi, S., & Lele, R. D. (2004) · PubMed · Cited by 1,575
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210 · cited 2×
“[73,239,308] The additional genes that are known to cause FALS include: TARDBP, encodes TAR DNAbinding protein 43 (TDP-43); FUS, which codes for fusion in sarcoma; ANG, which codes for angiogenin, ribonuclease, and the RNAase A family 5; OPTN, which codes for optineurin; and C9orf72.[23,49,56,100,135,160,179]”
BackgroundElectrodiagnostic criteria for diagnosis of ALS
de Carvalho, M., Dengler, R., Eisen, A., England, J. D., Kaji, R., Kimura, J., Mills, K., Mitsumoto, H., Nodera, H., Shefner, J., et al. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.09.143 · Cited by 1,194
The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03501.x · Cited by 1,117
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107 · cited 1×
“Some studies have demonstrated a decreased activity of respiratory chain complexes I and IV that are associated with defective energy metabolism.[234]”
BackgroundRiluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R., Mitchell, J., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 909
Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration
Sheng, Z.-H., & Cai, Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3156 · Cited by 903
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4)
Chen, Y.-Z., Bennett, C. L., Huynh, H. M., Blair, I. P., Puls, I., Irobi, J., Dierick, I., Abel, A., Kennerson, M. L., Rabin, B. A., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/421054 · Cited by 808
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0141 · Cited by 807
Incidence of amyotrophic lateral sclerosis in Europe
Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E., & EURALS, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183525 · Cited by 772 · cited 6×
“86).[2,170,228,305] Multiple studies have shown an increased risk in the male to female ratio (male: female =1.”
BackgroundResultInfluentialFunctional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model
Li, M., Ona, V. O., Guégan, C., Chen, M., Jackson-Lewis, V., Andrews, L. J., Olszewski, A. J., Stieg, P. E., Lee, J.-P., Przedborski, S., et al. (2000) · Science · doi:10.1126/science.288.5464.335 · Cited by 716
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Lomen-Hoerth, C., Anderson, T., & Miller, B. (2002) · Neurology · doi:10.1212/wnl.59.7.1077 · Cited by 699
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Lin, C.-L. G., Bristol, L. A., Jin, L., Dykes-Hoberg, M., Crawford, T., Clawson, L., & Rothstein, J. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80997-6 · Cited by 671
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649
Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) · Annals of Neurology · doi:10.1002/ana.410390203 · Cited by 645
Williamson, T. L., & Cleveland, D. W. (1999) · Nature Neuroscience · doi:10.1038/4553 · Cited by 637
Gijselinck, I., Van Langenhove, T., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., Janssens, J., Bettens, K., Van Cauwenberghe, C., Pereson, S., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70261-7 · Cited by 633
Prevalence and incidence of Parkinson's disease in Europe
von Campenhausen, S., Bornschein, B., Wick, R., Bötzel, K., Sampaio, C., Poewe, W., Oertel, W., Siebert, U., Berger, K., & Dodel, R. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.007 · Cited by 625
Clinical diagnosis and management of amyotrophic lateral sclerosis
Hardiman, O., van den Berg, L. H., & Kiernan, M. C. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.153 · Cited by 621
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Barber, S. C., & Shaw, P. J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.018 · Cited by 617
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.152 · Cited by 615 · cited 4×
“In several experiment with mutant SOD1 mice, loss of neurotrophic signaling and defective axonal transport were observed early in the disease process.[88,145,324] Both anterograde and retrograde transport were impaired by the presence of mutant SOD1.”
BackgroundInfluentialRiolo, S. A., Nguyen, T. A., Greden, J. F., & King, C. A. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.047225 · Cited by 595
Poisoning due to organophosphate insecticides
Namba, T., Nolte, C. T., Jackrel, J., & Grob, D. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90337-8 · Cited by 585
Series Introduction: Neurodegeneration: What is it and where are we?
Przedborski, S., Vila, M., & Jackson-Lewis, V. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17522 · Cited by 584
Mitchell, J., & Borasio, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60944-1 · Cited by 561
Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria
Liu, J., Lillo, C., Jonsson, P. A., Velde, C. V., Ward, C. M., Miller, T. M., Subramaniam, J. R., Rothstein, J. D., Marklund, S., Andersen, P. M., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.016 · Cited by 506
Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J., Hyman, B. T., Trotti, D., & Brown, R. H. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.021 · Cited by 506
GIBB, W. R. G., LUTHERT, P. J., & MARSDEN, C. D. (1989) · Brain · doi:10.1093/brain/112.5.1171 · Cited by 499
Traynor, B. J. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1258 · Cited by 493
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
Chio, A. (2005) · Brain · doi:10.1093/brain/awh373 · Cited by 484
Wenning, G. K., Colosimo, C., Geser, F., & Poewe, W. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00662-8 · Cited by 469
Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain Barrier
Smith, Q. R., Momma, S., Aoyagi, M., & Rapoport, S. I. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb01039.x · Cited by 454
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
Logroscino, G., Traynor, B. J., Hardiman, O., Chio', A., Couratier, P., Mitchell, J. D., Swingler, R. J., Beghi, E., & EURALS, F. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104828 · Cited by 448
Wijesekera, L. C., & Nigel Leigh, P. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-3 · Cited by 442
A hypothesis of chronic back pain: ligament subfailure injuries lead to muscle control dysfunction
Panjabi, M. M. (2006) · European Spine Journal · doi:10.1007/s00586-005-0925-3 · Cited by 423
De Vos, K. J., Chapman, A. L., Tennant, M. E., Manser, C., Tudor, E. L., Lau, K.-F., Brownlees, J., Ackerley, S., Shaw, P. J., McLoughlin, D. M., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm226 · Cited by 420
Deficits in axonal transport precede ALS symptoms in vivo
Bilsland, L. G., Sahai, E., Kelly, G., Golding, M., Greensmith, L., & Schiavo, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006869107 · Cited by 418
Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment
Din, J. N., Newby, D. E., & Flapan, A. D. (2004) · BMJ · doi:10.1136/bmj.328.7430.30 · Cited by 410
van Es, M. A., Veldink, J. H., Saris, C. G. J., Blauw, H. M., van Vught, P. W. J., Birve, A., Lemmens, R., Schelhaas, H. J., Groen, E. J. N., Huisman, M. H. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.442 · Cited by 399
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
Shigeri, Y., Seal, R. P., & Shimamoto, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.004 · Cited by 391
Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis
Lyall, R. A. (2001) · Brain · doi:10.1093/brain/124.10.2000 · Cited by 384
Alexianu, M. E., Ho, B., Mohamed, A. H., La Bella, V., Smith, R. G., & Appel, S. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360608 · Cited by 375
Trotti, D., Rolfs, A., Danbolt, N. C., Brown, R. H., & Hediger, M. A. (1999) · Nature Neuroscience · doi:10.1038/8091 · Cited by 373
The natural history of primary lateral sclerosis
Gordon, P. H., Cheng, B., Katz, I. B., Pinto, M., Hays, A. P., Mitsumoto, H., & Rowland, L. P. (2006) · Neurology · doi:10.1212/01.wnl.0000200962.94777.71 · Cited by 369
Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis
Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., McLaughlin, R., & Hardiman, O. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.224501 · Cited by 351
Miller, R. G., Petajan, J. H., Bryan, W. W., Armon, C., Barohn, R. J., Goodpasture, J. C., Hoagland, R. J., Parry, G. J., Ross, M. A., Stromatt, S. C., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390215 · Cited by 345
Multidisciplinary ALS care improves quality of life in patients with ALS
Van den Berg, J. P., Kalmijn, S., Lindeman, E., Veldink, J. H., de Visser, M., Van der Graaff, M. M., Wokke, J. H. J., & Van den Berg, L. H. (2005) · Neurology · doi:10.1212/01.wnl.0000180717.29273.12 · Cited by 343
Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis
Mazzini, L., Corrà, T., Zaccala, M., Mora, G., Del Piano, M., & Galante, M. (1995) · Journal of Neurology · doi:10.1007/bf00866922 · Cited by 339
Leigh, P. N., & Ray-Chaudhuri, K. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.886 · Cited by 331
Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden
Simpson, E. P., Henry, Y. K., Henkel, J. S., Smith, R. G., & Appel, S. H. (2004) · Neurology · doi:10.1212/wnl.62.10.1758 · Cited by 327
Busch, M. A., Maske, U. E., Ryl, L., Schlack, R., & Hapke, U. (2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-013-1688-3 · Cited by 322
Fink, J. K. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-996-0011-1 · Cited by 321
Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
Saccon, R. A., Bunton-Stasyshyn, R. K. A., Fisher, E. M. C., & Fratta, P. (2013) · Brain · doi:10.1093/brain/awt097 · Cited by 317
Suzuki, M., McHugh, J., Tork, C., Shelley, B., Klein, S. M., Aebischer, P., & Svendsen, C. N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000689 · Cited by 311
Ochs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515197 · Cited by 302
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
Jan Groeneveld, G., Veldink, J. H., van der Tweel, I., Kalmijn, S., Beijer, C., de Visser, M., Wokke, J. H. J., Franssen, H., & Berg, L. H. V. D. (2003) · Annals of Neurology · doi:10.1002/ana.10554 · Cited by 283
Genetics of familial amyotrophic lateral sclerosis
Valdmanis, P. N., & Rouleau, G. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296811.19811.db · Cited by 281
Head Injury and Amyotrophic Lateral Sclerosis
Chen, H., Richard, M., Sandler, D. P., Umbach, D. M., & Kamel, F. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm153 · Cited by 279
The epidemiology of motor neuron diseases: a review of recent studies
Worms, P. M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00630-x · Cited by 278
Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis
Menzies, F. M. (2002) · Brain · doi:10.1093/brain/awf167 · Cited by 277
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria
Vande Velde, C., Miller, T. M., Cashman, N. R., & Cleveland, D. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712209105 · Cited by 274
Czaplinski, A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.072660 · Cited by 273
Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology
Huisman, M. H. B., de Jong, S. W., van Doormaal, P. T. C., Weinreich, S. S., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H., & van den Berg, L. H. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.244939 · Cited by 270
Progression of Symptoms in the Early and Middle Stages of Huntington Disease
Kirkwood, S. C., Su, J. L., Conneally, P. M., & Foroud, T. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.273 · Cited by 269
Bordet, T., Buisson, B., Michaud, M., Drouot, C., Galéa, P., Delaage, P., Akentieva, N. P., Evers, A. S., Covey, D. F., Ostuni, M. A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123000 · Cited by 266
Desnuelle, C., Dib, M., Garrel, C., & Favier, A. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201300079364 · Cited by 264
Yoshino, H., & Kimura, A. (2006) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960600881870 · Cited by 263
Shaw, P., & Eggett, C. J. (2000) · Journal of Neurology · doi:10.1007/bf03161151 · Cited by 261
Reis-Filho, J. S. (2009) · Breast Cancer Research · doi:10.1186/bcr2431 · Cited by 260
Smith, R. G., Henry, Y. K., Mattson, M. P., & Appel, S. H. (1998) · Annals of Neurology · doi:10.1002/ana.410440419 · Cited by 257
Mitochondrial Alterations in the Spinal Cord of Patients With Sporadic Amyotrophic Lateral Sclerosis
Sasaki, S., & Iwata, M. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802c396b · Cited by 256
Cervical Spondylotic Myelopathy: Diagnosis and Treatment
Emery, S. E. (2001) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-200111000-00003 · Cited by 256
Blair, I. P., Williams, K. L., Warraich, S. T., Durnall, J. C., Thoeng, A. D., Manavis, J., Blumbergs, P. C., Vucic, S., Kiernan, M. C., & Nicholson, G. A. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.194399 · Cited by 255
Simkó, M., & Mattsson, M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20198 · Cited by 254
Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis
Kühnlein, P., Gdynia, H.-J., Sperfeld, A.-D., Lindner-Pfleghar, B., Ludolph, A. C., Prosiegel, M., & Riecker, A. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0853 · Cited by 252
Vijayvergiya, C., Beal, M. F., Buck, J., & Manfredi, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4385-04.2005 · Cited by 251
Correlates of suffering in amyotrophic lateral sclerosis
Ganzini, L., Johnston, W. S., & Hoffman, W. F. (1999) · Neurology · doi:10.1212/wnl.52.7.1434 · Cited by 250
Awaji Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis: A Systematic Review
Costa, J., Swash, M., & de Carvalho, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.254 · Cited by 249
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
Sorenson, E. J., Windbank, A. J., Mandrekar, J. N., Bamlet, W. R., Appel, S. H., Armon, C., Barkhaus, P. E., Bosch, P., Boylan, K., David, W. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000335970.78664.36 · Cited by 243
Amyotrophic Lateral Sclerosis Mimic Syndromes: A Population-Based Study
Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.109 · Cited by 242
A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice
Kieran, D., Hafezparast, M., Bohnert, S., Dick, J. R. T., Martin, J., Schiavo, G., Fisher, E. M. C., & Greensmith, L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501085 · Cited by 240
Occupational Exposures and Amyotrophic Lateral Sclerosis. A Population-based Case-Control Study
McGuire, V., Longstreth, W. T., Nelson, L. M., Koepsell, T. D., Checkoway, H., Morgan, M. S., & van Belle, G. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009070 · Cited by 236
Chio, A. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083402 · Cited by 232
The management of motor neurone disease
Leigh, P. N. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.suppl_4.iv32 · Cited by 226
Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies
Vucic, S., Rothstein, J. D., & Kiernan, M. C. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.05.006 · Cited by 225
Prevalence of depressive disorders and change over time in late-stage ALS
Rabkin, J. G., Albert, S. M., Del Bene, M. L., O'Sullivan, I., Tider, T., Rowland, L. P., & Mitsumoto, H. (2005) · Neurology · doi:10.1212/01.wnl.0000167187.14501.0c · Cited by 223
Disease progression in amyotrophic lateral sclerosis: Predictors of survival
Magnus, T., Beck, M., Giess, R., Puls, I., Naumann, M., & Toyka, K. V. (2002) · Muscle & Nerve · doi:10.1002/mus.10090 · Cited by 222
Chang, Y., Kong, Q., Shan, X., Tian, G., Ilieva, H., Cleveland, D. W., Rothstein, J. D., Borchelt, D. R., Wong, P. C., & Lin, C.-L. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002849 · Cited by 219
Mitochondrial dysfunction and its role in motor neuron degeneration in ALS
Manfredi, G., & Xu, Z. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.01.002 · Cited by 215
Pujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214 · cited 1×
“Adrenomyeloneuropathy X-linked inherited metabolic disorder causing demyelination[241] Detection of abnormal accumulation of very long chain fatty acids in plasma or red cells[212]”
BackgroundMutation of SOD1 in ALS: a gain of a loss of function
Sau, D., De Biasi, S., Vitellaro-Zuccarello, L., Riso, P., Guarnieri, S., Porrini, M., Simeoni, S., Crippa, V., Onesto, E., Palazzolo, I., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm110 · Cited by 212
Wang, S.-J., Wang, K.-Y., & Wang, W.-C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.019 · Cited by 210
Debono, M.-W., Le Guern, J., Canton, T., Doble, A., & Pradier, L. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90147-a · Cited by 210
Menon, P., Geevasinga, N., Yiannikas, C., Howells, J., Kiernan, M. C., & Vucic, S. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00014-9 · Cited by 209
Shoemaker, J. L., Seely, K. A., Reed, R. L., Crow, J. P., & Prather, P. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04346.x · Cited by 207
Andersen, P. M., Borasio, G. D., Dengler, R., Hardiman, O., Kollewe, K., Leigh, P. N., Pradat, P., Silani, V., & Tomik, B. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701262376 · Cited by 206
Bradley, W. G., & Mash, D. C. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903286009 · Cited by 205
Kiaei, M., Kipiani, K., Petri, S., Chen, J., Calingasan, N. Y., & Beal, M. F. (2005) · Neurodegenerative Diseases · doi:10.1159/000090364 · Cited by 199
Forsberg, K., Andersen, P. M., Marklund, S. L., & Brännström, T. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0805-3 · Cited by 199
Riviere, M., Meininger, V., Zeisser, P., & Munsat, T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.4.526 · Cited by 198
Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004
O'Toole, O., Traynor, B. J., Brennan, P., Sheehan, C., Frost, E., Corr, B., & Hardiman, O. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.117788 · Cited by 197
Nobile-Orazio, E. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00266-1 · Cited by 195
Singer, M. A., Statland, J. M., Wolfe, G. I., & Barohn, R. J. (2007) · Muscle & Nerve · doi:10.1002/mus.20728 · Cited by 195
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy
Cats, E. A., van der Pol, W.-L., Piepers, S., Franssen, H., Jacobs, B. C., van den Berg-Vos, R. M., Kuks, J. B., van Doorn, P. A., van Engelen, B. G., Verschuuren, J. J., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f0738e · Cited by 194
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family
Boxer, A. L., Mackenzie, I. R., Boeve, B. F., Baker, M., Seeley, W. W., Crook, R., Feldman, H., Hsiung, G.-Y. R., Rutherford, N., Laluz, V., et al. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.204081 · Cited by 194
Survival in Amyotrophic Lateral Sclerosis: The Role of Psychological Factors
McDonald, E. R. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540130027010 · Cited by 193 · cited 1×
“[38,77,151] The results were echoed in other studies that have indicated a greater likelihood of ALS development and progression when examining patients with a high rate of psychological disorders.[189]”
ResultPalliative care in amyotrophic lateral sclerosis
Borasio, G. D., Voltz, R., & Miller, R. G. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70049-9 · Cited by 193
Neuroprotective agents for clinical trials in ALS: A systematic assessment
Traynor, B. J., Bruijn, L., Conwit, R., Beal, F., O’Neill, G., Fagan, S. C., & Cudkowicz, M. E. (2006) · Neurology · doi:10.1212/01.wnl.0000223353.34006.54 · Cited by 193
Fatigue and depression are associated with poor quality of life in ALS
Lou, J.-S., Reeves, A., Benice, T., & Sexton, G. (2003) · Neurology · doi:10.1212/01.wnl.0000042781.22278.0a · Cited by 192
Graf, M., Ecker, D., Horowski, R., Kramer, B., Riederer, P., Gerlach, M., Hager, C., Ludolph, A. C., Kramer, B., Ecker, D., et al. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0220-1 · Cited by 192
FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
Kabashi, E., Bercier, V., Lissouba, A., Liao, M., Brustein, E., Rouleau, G. A., & Drapeau, P. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002214 · Cited by 190
A cross sectional study on determinants of quality of life in ALS
Chio, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033100 · Cited by 190 · cited 2×
“[24,95,113,242,287,322] Depression has a negative effect on the quality of life of patients with ALS.[52,156,173] In a recent study, 131 patients with ALS were evaluated to estimate the prevalence of depression.”
BackgroundResultRandomized, Double-Blind, Controlled Trial of Acetylcysteine in Amyotrophic Lateral Sclerosis
Louwerse, E. S., Weverling, G. J., Bossuyt, P. M. M., Meyjes, F. E. P., & de Jong, J. M. B. V. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540300031009 · Cited by 188
Total manifestations of amyotrophic lateral sclerosis
Hayashi, H., & Kato, S. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90158-5 · Cited by 184
Talbot, K. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.923.513 · Cited by 180
Tortarolo, M., Veglianese, P., Calvaresi, N., Botturi, A., Rossi, C., Giorgini, A., Migheli, A., & Bendotti, C. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00022-8 · Cited by 180
Kurt, A., Nijboer, F., Matuz, T., & K??bler, A. (2007) · CNS Drugs · doi:10.2165/00023210-200721040-00003 · Cited by 177
Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS
Carrì, M. T., Valle, C., Bozzo, F., & Cozzolino, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00041 · Cited by 174
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
Kawamata, H., & Manfredi, G. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.003 · Cited by 173
Lead Exposure and Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Munsat, T. L., Shefner, J. M., Hu, H., & Sandler, D. P. (2002) · Epidemiology · doi:10.1097/00001648-200205000-00012 · Cited by 172
Bensimon, G., Lacomblez, L., Delumeau, J. C., Bejuit, R., Truffinet, P., & Meininger, V. (2002) · Journal of Neurology · doi:10.1007/s004150200071 · Cited by 172
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis
Corrado, L., Del Bo, R., Castellotti, B., Ratti, A., Cereda, C., Penco, S., Sorarù, G., Carlomagno, Y., Ghezzi, S., Pensato, V., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.071027 · Cited by 170
Clinical care of patients with amyotrophic lateral sclerosis
Radunović, A., Mitsumoto, H., & Leigh, P. N. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70244-2 · Cited by 170
Misregulated RNA processing in amyotrophic lateral sclerosis
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Bennett, C. F., Cleveland, D. W., & Yeo, G. W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.059 · Cited by 169
Ticozzi, N., Vance, C., LeClerc, A. L., Keagle, P., Glass, J. D., McKenna‐Yasek, D., Sapp, P. C., Silani, V., Bosco, D. A., Shaw, C. E., et al. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31158 · Cited by 169
Epidemiology of amyotrophic lateral sclerosis.
Kurtzke, J. F. (1982) · PubMed · Cited by 168
Fitting, J.-W., Paillex, R., Hirt, L., Aebischer, P., & Schluep, M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6<887::aid-ana11>3.0.co;2-l · Cited by 168
Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Wunderink, W., Koster, A., de Vries, J. H. M., van der Luyt, J., Wokke, J. H. J., & van den Berg, L. H. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083378 · Cited by 167
Beers, D. R., Ho, B., Siklós, L., Alexianu, M. E., Mosier, D. R., Mohamed, A. H., Otsuka, Y., Kozovska, M. E., McAlhany, R. E., Smith, R. G., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00582.x · Cited by 166
Amyotrophic Lateral Sclerosis in South-East England: A Population-Based Study
Abhinav, K., Stanton, B. R., Johnston, C. A., Hardstaff, J. L., Orrell, R. W., Howard, R., Clarke, J., Sakel, M., Ampong, M. A., Shaw, C. E., et al. (2007) · Neuroepidemiology · doi:10.1159/000108917 · Cited by 164
Severity of Depressive Symptoms and Quality of Life in Patients with Amyotrophic Lateral Sclerosis
Kübler, A., Winter, S., Ludolph, A. C., Hautzinger, M., & Birbaumer, N. (2005) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968305276583 · Cited by 163
Sleep-disordered breathing and respiratory failure in acid maltase deficiency
Mellies, U., Ragette, R., Schwake, C., Baethmann, M., Voit, T., & Teschler, H. (2001) · Neurology · doi:10.1212/wnl.57.7.1290 · Cited by 162
Wang, H., O’Reilly, É. J., Weisskopf, M. G., Logroscino, G., McCullough, M. L., Schatzkin, A. G., Kolonel, L. N., & Ascherio, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq416 · Cited by 162
Motor neuron disease: THE BARE ESSENTIALS
Talbot, K. (2009) · Practical Neurology · doi:10.1136/jnnp.2009.188151 · Cited by 159
Johnson, F. O., & Atchison, W. D. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.07.010 · Cited by 159
Mórotz, G. M., Vos, K. J. D., Vagnoni, A., Ackerley, S., Shaw, C. E., & Miller, C. C. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds011 · Cited by 159
CELLULAR INTERACTIONS BETWEEN LEAD AND CALCIUM
Simons, T. J. B. (1986) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072162 · Cited by 159
Prospective study of chemical exposures and amyotrophic lateral sclerosis
Weisskopf, M. G., Morozova, N., O’Reilly, É. J., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.156976 · Cited by 158
Diagnosis of amyotrophic lateral sclerosis
Rowland, L. P. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00193-2 · Cited by 158
Apraxia of speech in degenerative neurologic disease
Duffy, J. R. (2006) · Aphasiology · doi:10.1080/02687030600597358 · Cited by 158
Control of Muscle Size During Disuse, Disease, and Aging
Degens, H., & Alway, S. E. (2006) · International Journal of Sports Medicine · doi:10.1055/s-2005-837571 · Cited by 155
Phase 2 study of sodium phenylbutyrate in ALS
Cudkowicz, M., Andres, P. L., MacDonald, S., Bedlack, R., Choudry, R., Brown, R. H., Jr., Zhang, H., Schoenfeld, D., Shefner, J. M., Matson, S. A., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802320487 · Cited by 154
Tolerance of high‐dose (3,000 mg/day) coenzyme Q10 in ALS
Ferrante, K. L., Shefner, J., Zhang, H., Betensky, R., O'Brien, M., Yu, H., Fantasia, M., Taft, J., Beal, M. F., Traynor, B., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187070.35365.d7 · Cited by 154
Gößwald, A., Schienkiewitz, A., Nowossadeck, E., & Busch, M. A. (2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-013-1666-9 · Cited by 153
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
Pascuzzi, R. M., Shefner, J. M., Chappell, A. S., Bjerke, J. S., Tamura, R., Chaudhry, V., Clawson, L., Haas, L., & Rothstein, J. D. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903307805 · Cited by 152
Chiò, A., Borghero, G., Pugliatti, M., Ticca, A., Calvo, A., Moglia, C., Mutani, R., Brunetti, M., Ossola, I., Marrosu, M. G., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.352 · Cited by 152
Nelson, L. M., Matkin, C. C., Longstreth, W. T., Jr., & McGuire, V. M. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010184 · Cited by 152
Phillips, J. L., Ivaschuk, O. I., Ishida-Jones, T., Jones, R. A., Campbell-Beachler, M., & Haggren, W. (1998) · Bioelectrochemistry and Bioenergetics · doi:10.1016/s0302-4598(98)00074-9 · Cited by 152
Chancellor, A. M., Slattery, J. M. A., Fraser, H., Swingler, R. J., Holloway, S. M., & Warlow, C. P. (1993) · Journal of Neurology · doi:10.1007/bf00839964 · Cited by 151
Mitochondrial Function, Morphology, and Axonal Transport in Amyotrophic Lateral Sclerosis
Magrané, J., & Manfredi, G. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2604 · Cited by 150
Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Guerra, V, Samarelli, V, Lepore, V, Simone, I. L., Lamberti, P., Serlenga, L., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.118018 · Cited by 147
Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS
Chiò, A., Finocchiaro, E., Meineri, P., Bottacchi, E., Schiffer, D., & the ALS Percutaneous Endoscopic Gastrostomy Study Group (1999) · Neurology · doi:10.1212/wnl.53.5.1123 · Cited by 144
Management Strategies for Patients With Amyotrophic Lateral Sclerosis From Diagnosis Through Death
Simmons, Z. (2005) · The Neurologist · doi:10.1097/01.nrl.0000178758.30374.34 · Cited by 144
Beghi, E., Logroscino, G., Chiò, A., Hardiman, O. M., Millul, A., Mitchell, D. J., Swingler, R. J., & Traynor, B. J. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903384283 · Cited by 144
Spencer, J. P. E., Jenner, A. M., Butler, J., Aruoma, O. I., Dexter, D. T., Jenner, P. G., & Halliwell, B. B. (1996) · Free Radical Research · doi:10.3109/10715769609088005 · Cited by 144
Ivanova, M. I., Sievers, S. A., Guenther, E. L., Johnson, L. M., Winkler, D. D., Galaleldeen, A., Sawaya, M. R., Hart, P. J., & Eisenberg, D. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320786110 · Cited by 143
Motor neuron disease presenting with respiratory failure
de Carvalho, M. A., Matias, T., Coelho, F., Evangelista, T., Pinto, A. C., & Luis, M. L. S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00089-5 · Cited by 140
Survival of Patients with Amyotrophic Lateral Sclerosis in a Population-Based Registry
Millul, A., Beghi, E., Logroscino, G., Micheli, A., Vitelli, E., & Zardi, A. (2005) · Neuroepidemiology · doi:10.1159/000086353 · Cited by 140
Respiratory aspects of neurological disease
Polkey, M. I., Lyall, R. A., Moxham, J., & Leigh, P. N. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.1.5 · Cited by 140
Kasarskis, E. J., Scarlata, D., Hill, R., Fuller, C., Stambler, N., & Cedarbaum, J. M. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00230-0 · Cited by 140
Amyotrophic lateral sclerosis: Early contributions of Jean-Martin Charcot
Goetz, C. G. (2000) · Muscle & Nerve · Cited by 140
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
Bordet, T., Berna, P. P., Abitbol, J., & Pruss, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3020345 · Cited by 140
Synergistic Effects of GDNF and VEGF on Lifespan and Disease Progression in a Familial ALS Rat Model
Krakora, D., Mulcrone, P. L., Meyer, M., Lewis, C. M., Bernau, K., Gowing, G., Zimprich, C., Aebischer, P., Svendsen, C. N., & Suzuki, M. (2013) · Molecular Therapy · doi:10.1038/mt.2013.108 · Cited by 139
Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy
Moser, H. W., Moser, A. B., Naidu, S., & Bergin, A. (1991) · Developmental Neuroscience · doi:10.1159/000112170 · Cited by 139
Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis
Piepers, S., Veldink, J. H., de Jong, S. W., van der Tweel, I., van der Pol, W. L., Uijtendaal, E. V., Schelhaas, H. J., Scheffer, H., de Visser, M., de Jong, J. M. B. V., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21620 · Cited by 137
Kiaei, M., KIPIANI, K., Calingasan, N. Y., Wille, E. J., CHEN, J., Heissig, B., Rafii, S., Lorenzl, S., & Beal, M. F. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.036 · Cited by 137
Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand ?
Henriques (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00032 · Cited by 134
Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model
Waibel, S., Reuter, A., Malessa, S., Blaugrund, E., & Ludolph, A. C. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0481-5 · Cited by 134
Davenport, R., Swingler, R. J., Chancellor, A. M., & Warlow, C. P. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.2.147 · Cited by 133
Vos, K. J. D., Severin, F. F., Herreweghe, F. V., Vancompernolle, K., Goossens, V., Hyman, A. A., & Grooten, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.6.1207 · Cited by 132
Phase II/III randomized trial of TCH346 in patients with ALS
Miller, R. G., Bradley, W. G., Cudkowicz, M., Hubble, J. P., Meininger, V., Mitsumoto, H., Moore, D. H., Pohlmann, H., Sauer, D., Silani, V., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000269676.07319.09 · Cited by 131
The El Escorial criteria: Strengths and weaknesses
Agosta, F., Al‐Chalabi, A., Filippi, M., Hardiman, O. M., Kaji, R., Meininger, V., Nakano, I., Shaw, P. J., Shefner, J. M., van den Berg, L. H., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.964258 · Cited by 131
The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over
Forbes, R. B. (2004) · Age and Ageing · doi:10.1093/ageing/afh013 · Cited by 131
Mathus-Vliegen, L., Louwerse, L. S., Merkus, M. P., Tytgat, G. N. J., & de Jong, J. M. B. V. (1994) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(94)70211-x · Cited by 130
Prevalence of depression in a 12‐month consecutive sample of patients with ALS
Wicks, P. J., Abrahams, S., Masi, D., Hejda-Forde, S., Leigh, P. N., & Goldstein, L. H. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01843.x · Cited by 130
Usefulness of Sniff Nasal Pressure in Patients with Neuromuscular or Skeletal Disorders
Stefanutti, D., Benoist, M. R., Scheinmann, P., Chaussain, M., & Fitting, J.-W. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9910034 · Cited by 126
de Carvalho, M. A., Pinto, S., Costa, J. N., Evangelista, T., Ohana, B., & Pinto, A. C. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.498521 · Cited by 125
Vucic, S., & Kiernan, M. C. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.105056 · Cited by 124
Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Ferrante, K. L., Bogdanov, M. B., Kaddurah-Daouk, R. F., & Beal, M. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00188.x · Cited by 123
Palliative care in amyotrophic lateral sclerosis
Borasio, G. D., & Voltz, R. (1997) · Journal of Neurology · doi:10.1007/pl00007719 · Cited by 123
Vielhaber, S., Winkler, K., Kirches, E., Kunz, D., Büchner, M., Feistner, H., Elger, C. E., Ludolph, A. C., Riepe, M. W., & Kunz, W. S. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00236-1 · Cited by 121
Hammer, E. M., Häcker, S., Hautzinger, M., Meyer, T., & Kübler, A. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.11.012 · Cited by 120
Cited by
Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules
Markmiller, S., Soltanieh, S., Server, K. L., Mak, R., Jin, W., Fang, M. Y., Luo, E.-C., Krach, F., Yang, D., Sen, A., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.032 · Cited by 911
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Roles of neuropathology-associated reactive astrocytes: a systematic review
Lawrence, J. M., Schardien, K., Wigdahl, B., & Nonnemacher, M. R. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01526-9 · Cited by 433
Liu, J., & Wang, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01005 · Cited by 376
Metadata
- Authors
- Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A.
- Venue
- Surgical Neurology International
- Publisher
- Scientific Scholar
- Published
- 2015
- Volume
- 6
- Issue
- 1
- Pages
- 171
- ISSN
- 2152-7806 (ISSN-L)
- OpenAlex
- W2186898572
- Cited by
- 709
- References
- 319
- FWCI
- 25.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.